Igc pharma announces patient enrollment at neurostudies in phase 2 trial investigating igc-ad1

Potomac, md.--(business wire)-- #ad--igc pharma announces patient enrollment at neurostudies, inc. in phase 2 trial investigating igc-ad1.
IGC Ratings Summary
IGC Quant Ranking